共 50 条
- [42] CARDIOVASCULAR AND ANTIHYPERTENSIVE ACTIVITIES OF THE NOVEL NON-SULFHYDRYL CONVERTING ENZYME-INHIBITOR 2-[N-[(S)-1-ETHOXYCARBONYL-3-PHENYLPROPYL]-L-ALANYL]-(1S,3S,5S)-2-AZABICYCLO[3.3.0]OCTANE-3-CARBOXYLIC ACID (HOE 498) ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1984, 34-2 (10B): : 1417 - 1425
- [43] EFFECTS OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR 2-[N-[(S)-1-ETHOXYCARBONYL-3-PHENYLPROPYL]-L-ALANYL]-(1S,3S,5S)-2-AZABICYCLO[3.3.0]OCTANE-3-CARBOXYLIC ACID (HOE 498) IN ESSENTIAL-HYPERTENSION ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1984, 34-2 (10B): : 1452 - 1454
- [47] Why is monoalkylation versus bis-alkylation of the Ni(II) complex of the Schiff base of (S)-N-(2-benzoylphenyl)-1-benzylpyrrolidine-2-carboxamide and glycine so selective? MP2 modelling and topological QTAIM analysis of chiral metallocomplex synthons of α-amino acids used for the preparation of radiopharmaceuticals for positron emission tomography Journal of Radioanalytical and Nuclear Chemistry, 2010, 286 : 829 - 833
- [48] Why is monoalkylation versus bis-alkylation of the Ni(II) complex of the Schiff base of (S)-N-(2-benzoylphenyl)-1-benzylpyrrolidine-2-carboxamide and glycine so selective? MP2 modelling and topological QTAIM analysis of chiral metallocomplex synthons of α-amino acids used for the preparation of radiopharmaceuticals for positron emission tomography JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2010, 286 (03) : 829 - 833
- [50] Crystal structure of ethyl 5"-(2,4-dichloroyphenyl)-1′-methyl-4-carboxylic acid methyl ester-2,3"-dioxo-2,3,2",3"-tetrahydro-1H-indole-3-spiro-2′-pyrrolidine-3′-spiro-2"-thiazolo[3",2"-a]-pyrimidine-6"-carboxylate, C29H26Cl2N4O6S ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2009, 224 (02): : 335 - 336